ESMO Media Releases

A subanalysis of the phase III ALEX study has shown that alectinib 600 mg twice daily is more effective than standard of care crizotinib in Asian patients with anaplastic lymphoma kinase (ALK) positive non-small-cell lung cancer (NSCLC), researchers report at the ESMO Asia 2017 Congress.

Just one in five Indonesian women are aware of cervical cancer screening, according to a study presented at the ESMO Asia 2017 Congress.

A study in Myanmar has found that all mouth cancer patients use smokeless tobacco, researchers report at the ESMO Asia 2017 Congress. Betel quid chewing often starts in adolescence and is associated with smoking and drinking alcohol, which are also risk factors for oral cancer.

A study that looked at mainstreaming genetic counselling for ovarian cancer to support screening programmes in Malaysia was presented at the ESMO Asia 2017 Congress.

Researchers have explored the analysis of mutations in cerebrospinal fluid of lung cancer patients with brain metastases in a study presented at the ESMO Asia 2017 Congress. 

The European Society for Medical Oncology (ESMO) opened its 3^rd ESMO Asia Congress today, once again in Singapore, attracting close to 3000 regional and international cancer doctors with leading researchers and experts to promote advances in science, diagnosis, treatment, and best practices for cancer patients in Asia

ESMO Asia 2017 Congress reveals the psychosocial impact on cancer survivors in Asia and their unmet needs. 

ESMO, the leading professional organisation for medical oncology, is pleased to announce the publication of the ESMO Precision Medicine Glossary in the Annals of Oncology.

The European Society for Medical Oncology (ESMO), the leading professional organisation for medical oncology, is pleased to announce the third ESMO Asia 2017 Congress. 

ESMO, the leading professional organisation for medical oncology, is pleased to announce the ESMO Asia 2017 Congress, which will be held 17 to 19 November at the Suntec Singapore Convention and Exhibition Centre.

ESMO President, Fortunato Ciardiello, has contributed an editorial on the priorities for future cancer research, to The Lancet Oncology with Josep Tabernero, ESMO President-Elect as co-author.

ESMO, the leading European professional organisation for medical oncology, was present at the WHO Global Conference on Noncommunicable Diseases (NCDs*) that finished last Friday in Montevideo, Uruguay.